Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GS-493 |
Trade Name | |
Synonyms | GS493|GS 493 |
Drug Descriptions |
GS-493 is a catalytic-site inhibitor of Shp2, which may result in decreased cell growth and inhibition of tumor growth (PMID: 25877780). |
DrugClasses | SHP2 Inhibitor 20 |
CAS Registry Number | 1710337-31-7 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
GS-493 | GS-493 | 0 | 0 |
GS-493 + Selumetinib | GS-493 Selumetinib | 0 | 0 |
GS-493 + Trametinib | GS-493 Trametinib | 0 | 0 |